多点射频微创治疗三叉神经痛的临床分析
Clinical Analysis of Multipoint Radiofrequency and Minimally Invasive Treatment for Trigeminal Neuralgia
周新平 1朱江1
作者信息
- 1. 焦作市第五人民医院神经外科,河南 焦作 454002
- 折叠
摘要
目的 探讨多点射频微创治疗对三叉神经痛患者疼痛及复发的影响.方法 选取 2021 年 1 月至 2023 年 1 月焦作市第五人民医院收治的150 例三叉神经痛患者,采用随机数字表法将其两组,每组各 75 例,对照组:药物治疗,观察组:多点射频微创治疗,比较两组患者的疼痛度、复发率、术后并发症、氧化应激指标水平及炎症因子水平.结果 两组患者治疗前疼痛度评分、氧化应激指标水平、炎症因子水平无明显差异(P>0.05),经治疗后,两组患者疼痛度评分、炎性因子水平、NO水平均较治疗前降低,且观察组患者更低,GSH-Px、SOD水平均升高,且观察组患者更高(P<0.05);组间复发率和并发症无差异(P>0.05).结论 多点射频微创治疗三叉神经痛,可有效减轻其疼痛度,且具有较高的安全性,值得推广.
Abstract
Objective To explore the effect of multi-point radiofrequency minimally invasive treatment on pain and recurrence in patients with trigeminal neuralgia.Methods 150 patients with trigeminal neuralgia admitted to the Fifth People's Hospital of Jiaozuo City from January 2021 to January 2023 were selected.They were divided into two groups using a random number table method,with 75 patients in each group.The control group received drug treatment,while the observation group received multi-point radiofrequency minimally invasive treatment.The pain level,recurrence rate,postoperative complications,oxidative stress index levels,and inflam-matory factor levels of the two groups were compared.Results Showed that there was no significant difference in pain score,oxidative stress index level,and inflammatory factor level between the two groups of patients before treatment(P>0.05).After treatment,the pain score,inflammatory factor level,and NO level of both groups of patients decreased compared to before treatment,and the obser-vation group had lower levels of GSH Px and SOD,and the observation group had higher levels(P<0.05);there was no difference in recurrence rate and complications between groups(P>0.05).Conclusion Multi point radiofrequency minimally invasive treatment for trigeminal neuralgia can effectively alleviate its pain and has high safety,which is worth promoting.
关键词
多点射频微创/三叉神经痛/疼痛/炎症因子Key words
multi point radiofrequency minimally invasive/trigeminal neuralgia/pain/inflammatory factors引用本文复制引用
基金项目
河南省医学科技攻关计划(LHGJ20220365)
出版年
2024